The Future Of Life Sciences Supply Chain Distribution

By Kerim Ozbilge, Sundip Naik, Nathan Silverman, and Camille Ostiguy

Life sciences distribution is at a pivotal turning point. Forces that once advanced gradually now converge at high speed: surging service expectations, tighter regulation, more diverse product portfolios, and relentless disruption. These pressures are exposing the limits of traditional, efficiency-only distribution models, pushing them toward breaking points.

In response, leading organizations are replacing fragmented logistics with integrated, adaptive, and resilient delivery networks. Powered by advanced automation, AI and physical AI (robotics), these networks are designed to weather disruptions and adjust in real time, maintaining the flow of critical health products. As a result, distribution is no longer managed as a cost center. Instead, it has become a strategic capability that provides continuity, supports growth, and upholds patient care even under stress.

A New Operating Environment For Life Sciences Supply Chains

Life sciences distribution has become increasingly complex, regulated, and time-critical, pushing organizations toward more resilient operating models. In response, many companies are adopting intelligent orchestration that uses real-time data and analytics to seamlessly connect warehouses, carriers, and last-mile delivery into a cohesive supply chain network that can adapt quickly to change. Physical AI and automation are transforming warehouse operations by improving productivity, accuracy, and safety, while reducing vulnerability to labor shortages and human error.

At the same time, end-to-end delivery networks supported by localized hubs and diverse last-mile strategies are enabling faster and more dependable service for specialized medical products that require careful handling or service. Building these capabilities requires sustained investment in data infrastructure, AI, automation, and workforce skills to create distribution systems that can withstand disruption rather than simply optimize for cost.

Six Trends Reshaping Life Sciences Distribution

Several macro trends are redefining the role of distributors across the life sciences value chain. Here are six of the key trends:

1. Customer and patient expectations are rising. Digital commerce has reshaped expectations across industries, including healthcare. Pharmacies, hospitals, and care providers increasingly expect shorter lead times, greater visibility, and more predictable delivery windows. In many markets, next-day or same-day delivery is becoming the benchmark for critical products.

• Proof point: Same-day prescription delivery is now widely available across the U.S., allowing many Americans to receive medications the same day they're ordered.¹

2. Regulatory and traceability requirements continue to expand. Global track-and-trace mandates, temperature control standards and reporting obligations have increased the need for end-to-end visibility, data integrity, and electronic interoperability. Compliance is no longer confined to documentation; it is embedded in daily operational decisions.

• Proof point: Regulatory mandates are converging on full supply chain traceability and globally aligned quality standards, with the Drug Supply Chain Security Act in the U.S. and the Falsified Medicines Directive in the European Union now enforcing serialized, end-to-end visibility.^2,3 In parallel, the U.S. Food and Drug Administration (FDA) Quality Management System Regulation (QMSR) shift to ISO 13485⁴,signals that compliance, data integrity, and monitoring must be embedded directly into daily operations, moving from documentation-driven to real-time operational accountability.

3. Product portfolios are becoming more complex. Growth in specialty and personalized medicines, combinations and advanced devices, and digitally enabled devices has introduced stricter handling, storage, and delivery requirements. These products place added pressure on warehouse design, transportation planning and last-mile execution.

• Proof point: While about 75% of pharmaceutical products in development are specialty therapies,⁵ MedTech portfolios are undergoing a parallel shift toward higher-complexity solutions: connected medical devices are growing at approximately 15% annually,⁶ driving a surge in distributed, service-intensive delivery requirements. In response, United States Pharmacopeia guidance reinforces stricter storage, transport, and handling controls for combination and temperature-sensitive medical products.⁷

4. Cost volatility and disruption persist. Geopolitical uncertainty, transportation cost swings, and labor constraints continue to affect distribution networks. Many organizations now plan for disruption as a constant rather than an exception.

• Proof point: Annual disruption events increased by 38% from 2024 to 2025.⁸ In addition, the 2025 edition of EY-Parthenon annual Geostrategy in Practice survey reveals that 63% of respondents reported that political risks caused negative impacts to their operations and supply chain.⁹

5. Workforce constraints are intensifying. Distribution operations are also struggling with labor shortages and skills gaps. These workforce challenges drive higher costs and limit throughput, underscoring the need for automated augmentation.

• Proof point: 59% of distribution operations face labor shortages, and persistent talent gaps are increasing costs and constraining operations.¹⁰ In response, companies are accelerating automation investments, with nearly half of logistics and warehousing tasks projected to be automated by 2030.¹¹

6. Technology adoption is accelerating. Many logistics providers are rapidly deploying advanced digital technologies, such as AI and Internet of Things (IoT), to increase efficiency. This approach also creates more data flows and operational complexity.

• Proof point: AI in logistics is growing at a 42% compound annual growth rate, reaching around $6 billion in 2026¹², and 78% of logistics firms use internet of things (IoT) tracking, which improves efficiency while increasing complexity.¹³

Together, these trends underscore the need for a new approach to distribution. Traditional, siloed logistics operations focused on local optimization are ill-suited for the complexity, speed, compliance demands, and volatility of today’s environment. Logistics and fulfillment must evolve into an integrated, orchestrated network that balances service, cost, compliance, and resilience across the enterprise.

Enabling An Intelligent, Orchestrated Life Sciences Delivery Network

To navigate this new landscape, life sciences organizations are shifting to an intelligent orchestrated delivery network model. This future-state operating approach connects physical assets, digital systems, and people through a shared layer of end-to-end visibility and AI-driven decision intelligence.

Rather than optimizing warehouses, transportation, or inventory in isolation, orchestration considers the network as a whole. Decisions about inventory placement, labor allocation, or delivery routing are informed by real-time data and executed in coordination across locations and partners.

At the center of this model is an AI-enabled orchestration layer, often described as a control tower. This layer integrates signals from warehouse management systems, transportation platforms, sensors, and external data sources. It translates those signals into actionable insights that support faster, more consistent decision-making.

The result is a distribution network that can respond dynamically to demand changes, capacity constraints, or disruptions, while maintaining compliance and service commitments.

AI-enabled Visibility And Decision Intelligence For Life Sciences

Visibility alone is no longer sufficient in complex distribution networks. Organizations increasingly require decision intelligence that helps determine what actions to take and when.

AI-enabled control towers aggregate operational data across the network and apply analytics and machine learning to identify patterns, anticipate issues, and recommend responses. For example, they can highlight emerging inventory imbalances, forecast capacity constraints, or flag shipments at risk of delay.

In practice, this decision intelligence allows organizations to shift from reactive firefighting to proactive management. Inventory can be repositioned before shortages occur, labor can be reallocated during peak periods, and transportation plans can be adjusted as conditions change.

Over time, these systems learn from outcomes, improving the quality of recommendations and supporting more consistent execution across the network.

Case study¹⁴

Smart Warehouses Powered By Physical AI And Automation

Warehouse operations sit at the core of distribution, yet persistent challenges remain. Labor is a major cost driver, with significant time spent on non-value-added movement. Additionally, inventory accuracy, safety, and space constraints continue to limit performance.

While automation is not new, physical AI changes the equation by embedding intelligence into warehouse equipment and workflows, allowing systems to see via cameras and sensors, make decisions using real-time data, and act through robotics without human intervention. In practice, this capability enables autonomous trailer loading and unloading, real-time facility inspection, and dynamic small-sort bagging and tendering operations that adapt to product flow and conditions. This shift moves life sciences warehousing from fixed, pre-programmed processes to responsive execution, improving throughput, reducing manual handling and strengthening compliance.

Real impact comes from embedding these capabilities into the operating model, with the right data, governance, and workforce enablement, rather than treating automation as a stand-alone solution.

Case study¹⁵

End-To-End Life Sciences Delivery Networks And Emerging Models

Orchestration also extends beyond the warehouse into the middle mile and final mile. To meet tighter delivery windows and improve resilience, many distributors are redesigning network footprints.

Localized hubs and micro-fulfillment centers allow fast-moving products to be staged closer to demand, supporting same-day or urgent deliveries. AI-driven transportation planning uses real-time data to adjust routes, balance loads, and manage capacity across modes.

Emerging delivery models, including autonomous vehicles and drones, are being tested for specific use cases such as remote access, congestion avoidance, or time-critical shipments. While adoption varies by market and regulatory environment, these models illustrate how orchestration can extend across diverse delivery options.

When connected through a shared orchestration layer, these elements support more responsive service while helping manage cost and sustainability trade-offs.

Case study¹⁶

Business Benefits Of An Orchestrated Life Sciences Delivery Network

An orchestrated, AI-enabled delivery network unlocks step-change performance by synchronizing decisions across inventory, transportation, and operations, thereby transforming distribution from a reactive cost center into a proactive, value-driving capability. By integrating real-time visibility with decision intelligence and automation, organizations can simultaneously improve service levels, reduce costs, and enhance resilience, delivering measurable gains across growth, efficiency and compliance:

Service and growth

• Improved on-time delivery performance
• Ability to support same-day fulfillment for critical products
• Enhanced customer and patient experience

Cost and productivity

• Reduced warehouse labor costs
• Better asset utilization
• Lower transportation cost per drop through optimized routing

Resilience and risk mitigation

• More proactive disruption management
• Fewer stockouts and improved inventory balance
• Stronger compliance and traceability

Operational efficiency

• Shorter order cycle times
• Higher throughput without proportional footprint expansion
• Fewer manual errors through automation and AI

Sustainability

• Optimized routing to reduce emissions
• Improved asset utilization to lower energy consumption
• Less waste through better forecasting and inventory management

A Strategic Approach To Life Sciences Supply Chain Distribution

Transforming life sciences distribution requires a deliberate, phased approach. Life sciences companies should consider the following focus areas to begin implementing an intelligent, orchestrated delivery network:

• Unified data platforms: Integrated, high-quality data across warehouses, transportation, and partners is essential for visibility and decision intelligence.
• AI and advanced analytics: Machine learning, forecasting, and scenario modeling support proactive planning and network-level decision-making.
• Automation and physical AI: Scalable automation, robotics, and intelligent equipment improve productivity, safety, and consistency in physical operations.
• Digital twins and simulation: Virtual models of facilities and networks support testing, planning, and continuous improvement.
• Workforce enablement: Skills, training, and change management help people work effectively with advanced technologies and new operating models.

These investments are not discrete initiatives. They are interdependent and most effective when developed as part of a coherent transformation roadmap.

About The Authors:

Kerim Ozbilge is a Partner in Life Sciences Supply Chain Consulting at EY, based in Chicago. He specializes in helping organizations achieve business transformation goals by improving supply chain performance, operational efficiency, resilience, and profitability. With more than 25 years of experience, Kerim has led end-to-end global supply chain transformation programs, from strategy and operating model design through implementation and business adoption. He is passionate about solving complex business challenges and driving sustainable growth through innovative, technology-enabled solutions. Kerim works with life sciences organizations to strengthen supply chains, enhance operational effectiveness and create long-term value in an increasingly dynamic market.

Sundip Naik is the EY Americas Leader for Logistics and Fulfillment, helping organizations transform supply chain operations across the Consumer Products & Retail, Advanced Manufacturing & Mobility, Health Sciences & Wellness, and Power & Utilities sectors. He brings more than 25 years of experience spanning both consulting and industry leadership roles. Prior to EY, Sundip served as Vice President of Logistics Strategy for a Fortune 35 retailer and Executive Vice President of Supply Chain for an instant commerce company, where he scaled fulfillment capabilities and improved operational profitability. He is recognized for driving value through innovation, process improvement and technology-enabled supply chain transformation.

Nathan Silverman is a Senior Manager in Supply Chain & Operations at EY, based in Nashville, Tennessee. He is an experienced supply chain and operations leader who helps Fortune 500 organizations transform their businesses through people-focused strategies that accelerate ROI, improve processes, and enhance customer satisfaction. Nathan has led global transformation programs across the end-to-end supply chain, with particular expertise in the life sciences and consumer products sectors. His work has supported COVID-19 vaccine launches, strengthened pharmaceutical supply resiliency, and improved access to life-saving medicines in low-income countries. He is also actively involved in community service through nonprofit board leadership.

Camille Ostiguy is a Senior Consultant within Supply Chain and Operations at EY. She specializes in global supply chain transformations, helping organizations across life sciences, consumer products, and advanced manufacturing connect strategy with execution. Her experience spans supply chain strategy, advanced planning, manufacturing and technology enablement. Camille brings together stakeholders, data-driven insights and innovative solutions to help organizations navigate change, strengthen resilience and build future-ready operations. Grounded in collaboration and purpose, she supports transformation initiatives that improve agility, enable informed decision-making and create lasting value.

References:

1. “Coast-to-Coast Convenience: Walmart’s Same-Day Pharmacy Delivery Now Available Across the United States,” Walmart website, https://corporate.walmart.com/news/2025/01/30/coast-to-coast-convenience-walmarts-same-day-pharmacy-delivery-now-available-across-the-united-states, January 30, 2025.
2. “Drug Supply Chain Security Act (DSCSA),” FDA website, https://www.fda.gov/drugs/drug-supply-chain-integrity/drug-supply-chain-security-act-dscsa, October 16, 2025.
3. “Falsified medicines,” European Commission website, https://health.ec.europa.eu/medicinal-products/falsified-medicines_en.
4. “Quality and Compliance (Medical Devices),” FDA website, https://www.fda.gov/medical-devices/device-advice-comprehensive-regulatory-assistance/quality-and-compliance-medical-devices, February 2, 2026.
5. “Navigating the Rapid Growth of Specialty Drugs: Opportunities, Challenges, and the Path Ahead,” Pharmacy Times website, https://www.pharmacytimes.com/view/navigating-the-rapid-growth-of-specialty-drugs-opportunities-challenges-and-the-path-ahead, September 2, 2024.
6. “Connected Medical Device Market Size & Share Analysis - Growth Trends and Forecast (2026 - 2031),” Mordor Intelligence website, https://www.mordorintelligence.com/industry-reports/connected-medical-device-market.
7. “USP General Chapter <1079>: Risks and Mitigation Strategies for the Storage and Transportation of Finished Products,” United States Pharmacopeia website, https://www.usp.org/sites/default/files/usp/document/supply-chain/apec-toolkit/USP%20GC1079.pdf, October 28, 2024.
8. “Illumination: 2025 Annual Supply Chain Report,” Resilinc website, https://resilinc.ai/learning-center/white-papers-reports/illumination-2025-annual-supply-chain-report-pdf/.
9. “The five habits of successful Geostrategists,” EY website, https://www.ey.com/en_us/insights/strategy-transactions/the-five-habits-of-successful-geostrategists, April 11, 2025.
10. https://www.descartes.com/resources/news/descartes-study-reveals-76-supply-chain-and-logistics-operations-are-experiencing
11. “United States Logistics & Warehousing Talent Gap & Shortage Diagnostics 2025: Shortage Roles, Time-To-Fill Risk, and Talent Availability (2025 Edition),” Talenbrium website, https://www.talenbrium.com/report/united-states-logistics-and-warehousing-talent-gap-and-shortage-diagnostics-2025, February 19, 2026.
12. AI in the Logistics Industry: 2026 Verified Stats & Trends
13. Logistic Industry Statistics (2026): Latest Research
14. “Case Study: Teva achieves 24/7 temperature and theft monitoring to safeguard medicine quality with FourKites (NIC‑Place),” CaseStudies.com website, https://www.casestudies.com/company/fourkites/case-study/leveraging-real-time-temperature-and-theft-tracking-to-ensure-the-highest-quality-transportation-and-improve-end-to-end-efficiency.
15. “Case Study: UPS Healthcare,” Locus Robotics website, https://locusrobotics.com/wp-content/uploads/2023/11/UPS-Healthcare-Case-Study.pdf.
16. "Cleveland Clinic to deliver drugs via drone,” Medical Device Supply Chain Council website, https://meddevicescc.org/2024/09/cleveland-clinic-to-deliver-drugs-via-drone.